H&Q LIFE SCIENCES INVESTORS (HQL) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 83 transactions totaling $14.8M, demonstrating a bullish sentiment with $10.1M in net insider flow. The most recent transaction on Dec 16, 2025 involved a purchase of 7,923 shares valued at $133.7K.
No significant insider buying has been recorded for HQL in the recent period.
No significant insider selling has been recorded for HQL in the recent period.
Based on recent SEC filings, insider sentiment for HQL is bullish with an Insider Alignment Score of 84/100 and a net flow of $10.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at H&Q LIFE SCIENCES INVESTORS (HQL) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading HQL stock, having executed 83 transactions in the past 90 days. The most active insider is Boaz Weinstein (Executive), who has made 19 transactions totaling $6.9M.
Get notified when executives and directors at HQL file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | Pittard Christian | Executive | Purchase | 7,923 | $16.88 | $133.7K | |
| Sep 22, 2025 | Management, L.p. Saba Capital | Executive | Sale | 41,623 | $14.14 | $588.5K | Large |
| Sep 19, 2025 | Management, L.p. Saba Capital | Executive | Sale | 6,989 | $14.10 | $98.5K | |
| Sep 18, 2025 | Management, L.p. Saba Capital | Executive | Sale | 40,208 | $14.07 | $565.7K | Large |
| Sep 17, 2025 | Management, L.p. Saba Capital | Executive | Sale | 24,328 | $13.99 | $340.3K | |
| Sep 16, 2025 | Management, L.p. Saba Capital | Executive | Sale | 2,026 | $13.99 | $28.3K | |
| Sep 15, 2025 | Management, L.p. Saba Capital | Executive | Sale | 700 | $14.13 | $9.9K | |
| Sep 11, 2025 | Management, L.p. Saba Capital | Executive | Sale | 15,116 | $14.28 | $215.9K | |
| Aug 29, 2025 | Weinstein Boaz | Executive | Sale | 23,723 | $13.89 | $329.5K | |
| Aug 26, 2025 | Management, L.p. Saba Capital | Executive | Sale | 400 | $13.83 | $5.5K | |
| Aug 21, 2025 | Management, L.p. Saba Capital | Executive | Sale | 10,710 | $14.07 | $150.7K | |
| Aug 23, 2024 | Maher Bill | Executive | Purchase | 650 | $15.37 | $10.0K | |
| Jul 16, 2024 | Dimartino Rose | Executive | Purchase | 1,000 | $15.53 | $15.5K | |
| Jun 26, 2024 | Weinstein Boaz | Executive | Purchase | 100 | $14.07 | $1.4K | |
| Jun 24, 2024 | Management, L.p. Saba Capital | Executive | Purchase | 13,812 | $14.08 | $194.5K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 66 | $12.4M | 82.0% |
Sale(S) | 11 | $2.4M | 15.6% |
Exercise (Options)(X) | 6 | $366.4K | 2.4% |
Insiders at H&Q LIFE SCIENCES INVESTORS are accumulating shares at an accelerated pace. With 16 insiders making 83 transactions totaling $12.4M in purchases versus $2.4M in sales, the net buying activity of $10.1M signals strong executive confidence. Boaz Weinstein (Executive) leads the buying activity with $6.9M in transactions across all time.